Notice2022-05802

Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 21, 2022

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 54 (Monday, March 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Pages 16001-16002]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463.

[[Page 16002]]

    Name of Committee: Safety and Occupational Health Study Section 
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
    Dates: June 14-15, 2022.
    Times: 11:00 a.m.-5:00 p.m., EDT.
    Place: Teleconference.
    Agenda: The meeting will convene to address matters related to the 
conduct of Study Section business and for the study section to consider 
safety and occupational health-related grant applications.

FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific 
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, West Virginia 
26506, Telephone: (304) 285-5951; Email: <a href="/cdn-cgi/l/email-protection#2b464c44474f484a465b6b484f48054c445d"><span class="__cf_email__" data-cfemail="e588828a898186848895a5868186cb828a93">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05802 Filed 3-18-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on March 21, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.